BIO Professional Development

Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth

Clinical Development 201: Phase I

Clinical Development 201: Phase I explores the prerequisites, purpose, design, and conduct of Phase I trials. Topics such as bioequivalence, pharmacokinetics, pharmacodynamics, endpoints, selection of dose, and more are explained in detail.

bio-course-directory-image-2 (1).png
Clinical Development 201: Phase I Course Trailer


  • Requirements for and maintenance of an Investigational New Drug (IND) application and a Clinical Trials Application (CTA).
  • Purpose of, and characteristics of Phase 0 and Phase I clinical trials.
  • Expectations related to clinical benefit in early clinical trials for a standard development programs, and development of treatments for conditions associated with serious unmet medical need.
  • Typical endpoints assessed in Phase I clinical trials.
  • Steps to take at the conclusion of the Phase I clinical study.

Download Course Syllabus

Clinical Development 201 Phase I Agenda
Course Price:
$150 USD
BIO Member Price:
$120 USD
Course Length:
55 minutes
Course Level:
Completion Period:
2 weeks
Course Format:

Certificate Requirements

  • View the entire course  
  • Pass course exam with a 70 percent  
  • Complete the course evaluation  
Suggested Prerequisites

Clinical Development 101: General Principles sets the stage for the entire clinical development process. Learn who conducts trials, how trials are conducted, and the various regulatory elements that must be performed throughout Phases I-IV trials.

Professional Certificate
Related Courses

A digital strategy can no longer lie within a siloed digital or innovation team. It’s critical to integrate digital across the enterprise to maintain a competitive edge.


Learn how to bring a drug successfully to market.

Professional Certificate

Do you need to understand the drug development process, including details about a drug's life cycle from its discovery through post-marketing studies?  This is the course for you.


The Regulatory Process provides a summary of the regulatory bodies involved in approving both small molecule drugs and biologics.

Professional Certificate